BRPI0511067A - processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular - Google Patents

processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular

Info

Publication number
BRPI0511067A
BRPI0511067A BRPI0511067-0A BRPI0511067A BRPI0511067A BR PI0511067 A BRPI0511067 A BR PI0511067A BR PI0511067 A BRPI0511067 A BR PI0511067A BR PI0511067 A BRPI0511067 A BR PI0511067A
Authority
BR
Brazil
Prior art keywords
molecular weight
gelatin
carrier
dosage forms
fish gelatin
Prior art date
Application number
BRPI0511067-0A
Other languages
English (en)
Inventor
Desmond Yik Teng Wong
Andrzej Jan Brzozowski
Leon Paul Grother
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of BRPI0511067A publication Critical patent/BRPI0511067A/pt
Publication of BRPI0511067B1 publication Critical patent/BRPI0511067B1/pt
Publication of BRPI0511067B8 publication Critical patent/BRPI0511067B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCESSO PARA A FORMULAçãO DE FORMAS DE DOSAGEM DE DISPERSãO RáPIDA COMPREENDENDO PELO MENOS UMA GELATINA DE PEIXE SELECIONADA COM BASE NO PESO MOLECULAR. A invenção descrita aqui, neste pedido de patente refere-se a uma composição farmacêutica que compreende um veículo e um ingrediente ativo, na qual o veículo é pelo menos uma gelatina de peixe predeterminada com base no perfil do peso molecular da gelatina. Em algumas modalidades, especificamente quando a concentração do veículo compreende uma percentagem relativamente baixa do total da composição, o veículo pode ser exclusivamente uma gelatina de peixe de alto peso molecular, ou pode ser composto de uma mistura com uma gelatina de peso molecular padrão, na qual a gelatina de alto peso molecular compreende uma parte predominante. Naquelas modalidades nas quais a concentração do veículo compreende uma percentagem relativamente maior do total da composição, o veículo pode ser uma gelatina de peixe exclusivamente de peso molecular padrão, ou pode ser composto por uma mistura na qual a gelatina de peso molecular padrão compreende uma parte predominante. Dessa forma, podem ser projetadas composições para otimizar o desempenho com relação a diversas formulações de concentrações de gelatina requeridas.
BRPI0511067A 2004-06-03 2005-06-03 processo para a formulação de formas de dosagem de dispersão rápida e forma de dosagem oral, sólida, de desintegração rápida de uma substância farmaceuticamente ativa BRPI0511067B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/860,106 US7972621B2 (en) 2004-06-03 2004-06-03 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
PCT/US2005/019589 WO2005120464A1 (en) 2004-06-03 2005-06-03 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Publications (3)

Publication Number Publication Date
BRPI0511067A true BRPI0511067A (pt) 2007-12-26
BRPI0511067B1 BRPI0511067B1 (pt) 2018-11-06
BRPI0511067B8 BRPI0511067B8 (pt) 2021-05-25

Family

ID=35449231

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511067A BRPI0511067B8 (pt) 2004-06-03 2005-06-03 processo para a formulação de formas de dosagem de dispersão rápida e forma de dosagem oral, sólida, de desintegração rápida de uma substância farmaceuticamente ativa

Country Status (19)

Country Link
US (1) US7972621B2 (pt)
EP (1) EP1765299B1 (pt)
JP (1) JP5144258B2 (pt)
KR (1) KR101161430B1 (pt)
CN (2) CN102172345B (pt)
AU (1) AU2005251773B2 (pt)
BR (1) BRPI0511067B8 (pt)
CA (1) CA2567830C (pt)
DK (1) DK1765299T3 (pt)
ES (1) ES2654293T3 (pt)
HU (1) HU230429B1 (pt)
IL (1) IL179777A (pt)
IS (1) IS8588A (pt)
MX (1) MXPA06013921A (pt)
NO (1) NO342135B1 (pt)
PL (2) PL218958B1 (pt)
RU (1) RU2415665C2 (pt)
WO (1) WO2005120464A1 (pt)
ZA (1) ZA200610664B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
CA2608716A1 (en) 2005-05-19 2006-11-23 Kilda Biolink As Gelatin-containing topical composition
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
JP5547096B2 (ja) * 2008-02-28 2014-07-09 アール．ピー． シェーラー テクノロジーズ エルエルシー 多型を最小化する方法
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
US9956169B2 (en) * 2010-10-08 2018-05-01 R.P. Scherer Technologies, Llc Oral vaccine fast-dissolving dosage form using starch
EP4371554A2 (en) 2016-12-31 2024-05-22 BioXcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
CN114983980A (zh) 2018-06-27 2022-09-02 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN117529324A (zh) 2021-06-11 2024-02-06 奥夫艾治疗公司 稳定的阿匹莫德组合物和其用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
US4760094A (en) 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4767789A (en) 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760093A (en) 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
CA2127702C (en) 1992-11-11 2000-11-07 Nobuyuki Kagami Polyester composition and film made therefrom
US6726928B2 (en) 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
AU2190697A (en) 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US6258380B1 (en) 1999-03-05 2001-07-10 Banner Pharmacaps, Inc. Chewable soft capsule
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US6709699B2 (en) * 2000-09-27 2004-03-23 Kabushiki Kaisha Toshiba Film-forming method, film-forming apparatus and liquid film drying apparatus
US6706669B2 (en) * 2001-07-13 2004-03-16 Exxonmobil Research And Engineering Company Method for inhibiting corrosion using phosphorous acid
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
GB2388776B (en) * 2002-05-21 2004-08-25 Croda Int Plc Succinylated fish gelatin for use as a blood plasma expander
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Also Published As

Publication number Publication date
PL382307A1 (pl) 2007-08-20
CN102172345A (zh) 2011-09-07
PL218958B1 (pl) 2015-02-27
WO2005120464A1 (en) 2005-12-22
IS8588A (is) 2006-12-28
PL1765299T3 (pl) 2018-05-30
EP1765299A4 (en) 2011-03-09
EP1765299B1 (en) 2017-11-15
NO342135B1 (no) 2018-03-26
NO20066070L (no) 2007-02-27
MXPA06013921A (es) 2007-01-26
HUP0700043A2 (en) 2009-03-02
CA2567830A1 (en) 2005-12-22
EP1765299A1 (en) 2007-03-28
DK1765299T3 (en) 2018-01-22
AU2005251773A1 (en) 2005-12-22
CA2567830C (en) 2013-08-13
CN102172345B (zh) 2018-05-04
BRPI0511067B1 (pt) 2018-11-06
ES2654293T3 (es) 2018-02-13
US7972621B2 (en) 2011-07-05
BRPI0511067B8 (pt) 2021-05-25
JP2008501709A (ja) 2008-01-24
KR101161430B1 (ko) 2012-07-02
IL179777A0 (en) 2007-05-15
KR20070039524A (ko) 2007-04-12
AU2005251773B2 (en) 2010-12-16
RU2006147244A (ru) 2008-07-20
HU230429B1 (hu) 2016-06-28
IL179777A (en) 2015-09-24
JP5144258B2 (ja) 2013-02-13
ZA200610664B (en) 2007-12-27
HUP0700043A3 (en) 2012-09-28
RU2415665C2 (ru) 2011-04-10
US20050271719A1 (en) 2005-12-08
CN1960710A (zh) 2007-05-09

Similar Documents

Publication Publication Date Title
BRPI0511067A (pt) processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular
Bar-Or et al. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use
BR0307893A (pt) Formulação oftálmica com sistema de goma
BRPI0615860B8 (pt) composição farmacêutica de liberação prolongada monolítica sólida
UY29157A1 (es) Composiciones de amitraz
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BRPI0513622A (pt) aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes
BRPI0506523A (pt) composição adesiva de époxi, seu uso e veìculo
BRPI0409068A (pt) composições farmacêuticas para inibidores de protease viral de hepatite c.
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
BR0013355A (pt) Tratamento com droga para a sìndrome da perna inquieta
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
BRPI0411165A (pt) composição farmacêutica, forma de unidade de dosagem e métodos para preparar seu uso
BRPI0514411B8 (pt) formulação, e, método de produzir uma formulação
Nakashima et al. Associations between low serum testosterone and all-cause mortality and infection-related hospitalization in male hemodialysis patients: a prospective cohort study
BRPI0418011A (pt) óleo de base lubrificante, e, processo e instalação de fabricação do mesmo
BR0212052A (pt) Preparação de composição farmacêutica de liberação prolongada
BRPI0607349A2 (pt) combinação de xolair com agente imunossupressor
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
BRPI0508680A (pt) composição de resfriamento natural, composição flavorizante, produto pronto-para-consumo, e, uso de uma composição
BR0210595A (pt) Regime de dosagem e composição farmacêutica para contracepção de emergência
BRPI0807528B1 (pt) sistema de liberação de composições lubrificantes pessoais complementares
BRPI0908539B8 (pt) processo para a preparação de uma forma sólida rápida de dosagem da dispersão, oral de alprazolam
BRPI0516224A (pt) produto alimentìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente alimentìcio bioativo de interesse, processo de preparação do mesmo, e, utilização de um produto alimentìcio

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/11/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF